Court Rules
All enforcement actions
SettlementMedium Risk

Made-in-China Settles with Connecticut AG Over Bootleg GLP-1 Drug Sales

Made-in-ChinaMay 6, 2026Connecticut Attorney General

Penalty Amount

$300,000

Summary

Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.

Remedy

Made-in-China must prohibit manufacturers from advertising or selling GLP-1s to U.S. customers, deploy a monitoring system to detect and remove such listings, and remove existing GLP-1 listings within five days. The company is subject to a $300,000 penalty, with $30,000 due initially and the remaining $270,000 suspended; additional penalties apply for settlement violations.

Monetary PenaltyInjunctionBanCompliance Program

Contract Impact

In-house legal teams at online trade platforms and e-commerce vendors should review vendor agreements and terms of service to add explicit prohibitions on selling unapproved FDA-regulated drugs, prescription-only medications, and misbranded health products without valid medical oversight. Contracts should include requirements for automated monitoring systems to detect non-compliant listings, specified timeframes for removing prohibited content, and penalty clauses with suspended amounts that trigger upon breach of terms. Platforms should also include indemnification provisions and audit rights to ensure vendor compliance with health and safety regulations.

Contract Search Terms

prohibited product clauseFDA compliancevendor monitoring systemunapproved drug salesprescription requirementlisting removal processsuspended penalty clausemedical oversight requirement

Laws Cited

Connecticut Unfair Trade Practices Act

Violation Types

Entity Details

Entity

Made-in-China

Industry

Other

Official Sources

Source Evidence

Event Date
"05/06/2026"
Entity Name
"Made-in-China"
Fine Amount
"$300,000 penalty to the state, suspended after $30,000"
Laws Cited
"violations of the Connecticut Unfair Trade Practices Act"
Summary
"unlawful sales of bootleg GLP-1 weight loss drugs direct to Connecticut consumers without prescriptions or any medical oversight"
Remedy Types
"prohibits manufacturers from using the platform to advertise or sell GLP-1s to customers in the United States"

Related Enforcement Actions

CT

Perry Johnson & Associates, Inc.; Perry Johnson, Inc.; Perry Johnson & Associates Coding, Inc.; Perry Johnson & Associates Radiology, Inc.; and Medical Transcription and Coding, Inc.

$10.0M

A March 2023 breach exposed personal and protected health information belonging to more than 13.3 million people after hackers accessed the companies’ systems, including unencrypted files, and security alerts were not properly configured. The companies agreed to pay at least $300,000 in penalties, with up to $9.7 million more due if they fail to comply, and to implement extensive security, incident-response, and data-handling reforms.

CT

United States Department of Justice

Connecticut Attorney General William Tong and a 23-state coalition obtained a court ruling declaring unlawful federal immigration-enforcement conditions placed on Congressionally authorized public safety grants. The court permanently enjoined the federal government from implementing or enforcing those conditions; the release does not describe a privacy violation or monetary penalty.

CT

Bipartisan coalition of 45 attorneys general

Connecticut Attorney General William Tong co-led a bipartisan coalition of 45 attorneys general urging Congress to pass the Kids Online Safety Act. This was a legislative advocacy effort, not a new enforcement action; the release discusses prior investigations into platforms’ effects on children and a separate Meta settlement.

CT

U.S. Census Bureau

Connecticut Attorney General William Tong joined a coalition of 24 attorneys general and two governors in opposing proposed changes to the 2030 Census. The coalition argued the proposal would exclude people from the count, remove demographic questions, and replace the usual-residence standard; this was a comment-letter action, not a penalty or enforcement order.

CT

Donald Trump and his co-defendants

Connecticut Attorney General William Tong joined attorneys general from 17 states in an amicus brief urging the New York Court of Appeals to preserve state authority to pursue fraud cases. The underlying civil case alleges that Donald Trump and his co-defendants inflated asset values to obtain better loan and insurance terms; this press release announces advocacy, not a new enforcement order or penalty.

CT

General Motors LLC

$220.0M

Connecticut and a coalition of 36 attorneys general reached a $220 million settlement with General Motors over the collection and sale of consumers’ driving behavior and location data to data brokers and insurers without adequate disclosure or consent. The settlement requires affirmative express consent before collecting or disclosing driving and location data, limits data collection, and imposes privacy program assessments and dealership oversight and training.